Bellevue F.(L)-B.Obesity Sol.I2 EUR/ LU1725387622 /
| NAV2024-05-02 | Chg.+0.1500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 164.8000EUR | +0.09% | reinvestment | Equity | Waystone M.Co.(Lux) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-05-05 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-01-03 | PRIIP Key Information Document | 2024 | English | 173.56 KB |
| 2024-01-03 | PRIIP Key Information Document | 2024 | German | 182.64 KB |
| 2023-12-31 | Semi-annual report | 2023 | English | 1,253.99 KB |
| 2023-12-31 | Semi-annual report | 2023 | German | 268.82 KB |
| 2023-11-27 | Prospectus | 2023 | English | 2,153.00 KB |
| 2023-11-27 | Prospectus | 2023 | German | 2,263.08 KB |
| 2023-06-30 | Account statment | 2023 | English | 6,012.84 KB |
| 2023-06-30 | Account statment | 2023 | German | 8,818.93 KB |
| 2022-01-31 | Key Investor Information | 2022 | English | 466.52 KB |
| 2022-01-31 | Key Investor Information | 2022 | German | 463.14 KB |
